Gan & Lee Pharmaceuticals 2025 Sustainability Report
Company: Gan & Lee Pharmaceuticals
Sector: Manufacturing
Country: China
Year: 2025
Type: Sustainability Report
Pages: 60
The report is Gan & Lee Pharmaceuticals' first ESG report and covers 2025 group practices and performance. It establishes a three-tier ESG governance structure with the Board as the highest decision-making body and conducts a double materiality assessment. Environmental disclosures report 30,774.37 tonnes of CO2 equivalent in Scope 1 and 37,702.14 tonnes of CO2 equivalent in Scope 2, alongside a target to reduce Scope 1 and Scope 2 emission intensity by 40% by 2030. The report also highlights 347,006 training participations and an average of 66.77 training hours per employee.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.